Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92492512 | 9249251 | 2 | F | 2008 | 20160805 | 20130423 | 20160812 | EXP | US-ASTRAZENECA-2013SE25285 | ASTRAZENECA | 0.00 | M | Y | 0.00000 | 20160812 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92492512 | 9249251 | 1 | PS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 160/4.5 MCG, 2 PUFFS, TWO TIMES A DAY | 21929 | ||||||||||
| 92492512 | 9249251 | 2 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | TWO TIMES A DAY | 0 | ||||||||||
| 92492512 | 9249251 | 3 | C | ALBUTEROL NEBULIZER | ALBUTEROL | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 92492512 | 9249251 | 4 | C | PRIMADONE | 2 | Oral | 0 | 50 | MG | BID | |||||||||
| 92492512 | 9249251 | 5 | C | PROPANOLOL | PROPRANOLOL HYDROCHLORIDE | 1 | Oral | 0 | 40 | MG | QID | ||||||||
| 92492512 | 9249251 | 6 | C | XANAX | ALPRAZOLAM | 1 | Oral | 0 | .5 | MG | QID | ||||||||
| 92492512 | 9249251 | 7 | C | VALIUM | DIAZEPAM | 1 | Oral | 5.0MG AS REQUIRED | 0 | 5 | MG | ||||||||
| 92492512 | 9249251 | 8 | C | VALIUM | DIAZEPAM | 1 | Oral | 5.0MG AS REQUIRED | 0 | 5 | MG | ||||||||
| 92492512 | 9249251 | 9 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 15 MG 4-5 DAILY | 0 | ||||||||||
| 92492512 | 9249251 | 10 | C | OXYGEN. | OXYGEN | 1 | Respiratory (inhalation) | 1.5 L/MIN COUNT | 0 | ||||||||||
| 92492512 | 9249251 | 11 | C | OXYGEN. | OXYGEN | 1 | Respiratory (inhalation) | DOSE INCREASED TO AROUND THE CLOCK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92492512 | 9249251 | 1 | Chronic obstructive pulmonary disease |
| 92492512 | 9249251 | 2 | Chronic obstructive pulmonary disease |
| 92492512 | 9249251 | 3 | Chronic obstructive pulmonary disease |
| 92492512 | 9249251 | 4 | Tremor |
| 92492512 | 9249251 | 5 | Tremor |
| 92492512 | 9249251 | 6 | Anxiety |
| 92492512 | 9249251 | 7 | Anxiety |
| 92492512 | 9249251 | 8 | Sleep disorder |
| 92492512 | 9249251 | 9 | Pain |
| 92492512 | 9249251 | 10 | Oxygen supplementation |
| 92492512 | 9249251 | 11 | Oxygen supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92492512 | 9249251 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92492512 | 9249251 | Chronic obstructive pulmonary disease | |
| 92492512 | 9249251 | Circumstance or information capable of leading to medication error | |
| 92492512 | 9249251 | Device use issue | |
| 92492512 | 9249251 | Dyspnoea | |
| 92492512 | 9249251 | Hypercapnia | |
| 92492512 | 9249251 | Intentional product misuse | |
| 92492512 | 9249251 | Product quality issue | |
| 92492512 | 9249251 | Productive cough | |
| 92492512 | 9249251 | Respiratory failure | |
| 92492512 | 9249251 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92492512 | 9249251 | 1 | 2008 | 0 | ||
| 92492512 | 9249251 | 4 | 2007 | 0 | ||
| 92492512 | 9249251 | 5 | 2007 | 0 | ||
| 92492512 | 9249251 | 6 | 2007 | 0 | ||
| 92492512 | 9249251 | 7 | 2007 | 0 | ||
| 92492512 | 9249251 | 8 | 2007 | 0 | ||
| 92492512 | 9249251 | 9 | 2009 | 0 | ||
| 92492512 | 9249251 | 10 | 2007 | 0 | ||
| 92492512 | 9249251 | 11 | 2008 | 0 |